Asia Pacific Apac Radiotherapy Market
Tamaño del mercado en miles de millones de dólares
Tasa de crecimiento anual compuesta (CAGR) :
% 
 Período de pronóstico |
2023 –2030 |
 Tamaño del mercado (año base) |
USD 1,595.61 Million |
 Tamaño del mercado (año de pronóstico) |
USD 3,321.79 Million |
 Tasa de crecimiento anual compuesta (CAGR) |
% |
| Jugadoras de los principales mercados |
|
>Mercado de radioterapia de Asia y el Pacífico, por producto y servicios (servicios, productos y software), tipo (radioterapia de haz externo, radioterapia interna, radioterapia sistémica/ radiofármacos y otros), aplicación (cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino, cáncer de columna y otros), usuario final (hospitales, centros de radioterapia, clínicas especializadas y otros), canal de distribución (licitaciones directas, distribuidores externos y otros): tendencias de la industria y pronóstico hasta 2030.
Análisis y tamaño del mercado de radioterapia en Asia y el Pacífico
La incidencia del cáncer en Asia y el Pacífico estaba aumentando, y la radioterapia es una modalidad de tratamiento crucial para muchos tipos de cáncer. A medida que la población sigue envejeciendo y los estilos de vida cambian, se espera que aumente el número de casos de cáncer, lo que impulsará la demanda de radioterapia. Una mayor conciencia sobre el cáncer y sus opciones de tratamiento, junto con mejores métodos de detección temprana y detección, llevaron a más personas a buscar tratamientos para el cáncer, incluida la radioterapia. En muchos países, el gasto en atención médica ha aumentado, lo que proporciona más fondos para tratamientos avanzados como la radioterapia. Los gobiernos y los proveedores de atención médica privados han estado invirtiendo en la modernización de sus instalaciones y equipos.
Data Bridge Market Research analiza que se espera que el mercado de radioterapia de Asia-Pacífico alcance un valor de USD 3.321,79 millones para 2030, desde USD 1.595,61 millones en 2022, creciendo a una CAGR del 10,0% durante el período de pronóstico. Este informe de mercado también cubre el análisis de precios y los avances tecnológicos en profundidad.
|
Métrica del informe |
Detalles |
|
Período de pronóstico |
2023 a 2030 |
|
Año base |
2022 |
|
Años históricos |
2021 (Personalizable para 2015 - 2020) |
|
Unidades cuantitativas |
Ingresos en millones de USD, volúmenes en unidades y precios en USD |
|
Segmentos cubiertos |
Producto y servicios (servicios, productos y software), tipo (radioterapia externa, radioterapia interna, radioterapia sistémica/radiofármacos y otros), aplicación (cáncer de mama, cáncer de pulmón, cáncer de próstata, cáncer colorrectal, linfoma, cáncer de hígado, cáncer de tiroides, cáncer de cerebro, cáncer de cuello uterino, cáncer de columna y otros), usuario final (hospitales, centros de radioterapia, clínicas especializadas y otros), canal de distribución (licitaciones directas, distribuidores externos y otros) |
|
Países cubiertos |
China, Japón, Australia, India, Corea del Sur, Nueva Zelanda, Singapur, Tailandia, Malasia, Vietnam, Taiwán, Indonesia, Filipinas y el resto de Asia-Pacífico. |
|
Actores del mercado cubiertos |
Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips NV, Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical System, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”) y Nordion Inc. (una subsidiaria de Sotera Health), entre otros. |
Definición de mercado
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation that will be delivered to the patient's tumor and the surrounding normal tissue.
Asia-Pacific Radiotherapy Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Growing Prevalence of Cancer Disease
The Asia-Pacific incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Cancer disease has a major impact Asia-Pacificly. Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel Technology in Radiotherapy for Cancer Treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing Healthcare Expenditure for Cancer Treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure helps the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Hence, the increasing healthcare expenditure for cancer treatment is expected to create an opportunity for market growth.
Restraint / Challenge
- Lack of Skilled and Certified Professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
The requirement for trained staff is a big issue for the radiotherapy market, due to which the lack of skilled and certified professionals, end users are not able to install advanced products of radiotherapy procedures, the reason, lack of skilled and certified professionals are expected to restrain market growth.
Asia-Pacific Radiotherapy Market Scope
The Asia-Pacific radiotherapy market is categorized into five notable segments which are on the basis of product and services, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product and Services
- Services
- Product
- Software
On the basis of product and services, the market is segmented into services, product, and software.
Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/ Radiopharmaceuticals
- Others
On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others.
Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Lymphoma
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
- Others
On the basis of application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others.
End User
- Hospitals
- Radiation Therapy Centers
- Specialty Clinics
- Others
On the basis of end user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others.
Distribution Channel
- Direct Tenders
- Third Party Distributors
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party distributors, and others.
Asia-Pacific Radiotherapy Market Regional Analysis/Insights
Asia-Pacific radiotherapy market is analyzed and market size insights and trends are provided by country, product and services, type, application, end user, and distribution channel as referenced above.
The countries covered in this market report are China, Japan, Australia, India, South Korea, New Zealand, Singapore, Thailand, Malaysia, Vietnam, Taiwan, Indonesia, Philippines, and Rest of Asia-Pacific.
China is expected to dominate the market with the largest market share due to advancements of healthcare system and rising prevalence of various types of cancer along with the largest patient pool.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Radiotherapy Market Share Analysis
El panorama competitivo del mercado de radioterapia de Asia-Pacífico proporciona detalles de los competidores. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, las nuevas iniciativas de mercado, la presencia en Asia-Pacífico, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos y el dominio de las aplicaciones. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado.
Algunos de los principales actores del mercado que operan en el mercado de radioterapia de Asia-Pacífico son Siemens Healthcare GmbH, Elekta, General Electric Company, Hitachi, Ltd., Koninklijke Philips NV, Zeiss International, IBA Worldwide, CANON MEDICAL SYSTEMS CORPORATION, Accuray Incorporated, Mevion medical Systems, Brainlab AG, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY) y NordionInc. (una subsidiaria de Sotera Health), entre otros.
SKU-
Obtenga acceso en línea al informe sobre la primera nube de inteligencia de mercado del mundo
- Panel de análisis de datos interactivo
- Panel de análisis de empresas para oportunidades con alto potencial de crecimiento
- Acceso de analista de investigación para personalización y consultas
- Análisis de la competencia con panel interactivo
- Últimas noticias, actualizaciones y análisis de tendencias
- Aproveche el poder del análisis de referencia para un seguimiento integral de la competencia
Tabla de contenido
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC RADIOTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE
2.8 MARKET END USERS COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
5 REGULATORY GUIDELINES FOR RADIOTHERAPY
5.1 INDIA REGULATORY GUIDELINE FOR RADIOTHERAPY
5.2 CHINA REGULATORY GUIDELINE FOR RADIOTHERAPY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMEN
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.3.1 EXTERNAL BEAM RADIOTHERAPY
7.3.1.1 LINAC
7.3.1.2 PROTON THERAPY
7.3.1.2.1 SYNCHROTRON
7.3.1.2.2 CYCLOTRON
7.3.1.3 CYBER KNIFE
7.3.1.4 GAMMA KNIFE
7.3.1.5 OTHERS
7.3.2 INTERNAL RADIATION RADIOTHERAPY
7.3.2.1 SEEDS
7.3.2.2 ELECTRONIC BRACHYTHERAPY
7.3.2.3 APPLICATORS
7.3.2.4 AFTERLOADERS
7.3.2.5 OTHERS
7.3.3 SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS
7.3.3.1 ALPHA EMITTERS
7.3.3.2 BETA EMITTERS
7.3.3.3 OTHERS
7.4 SOFTWARE
7.4.1 IMAGE GUIDING SOFTWARE
7.4.2 TREATMENT PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 DOSAGE PLANNING SOFTWARE
7.4.5 OTHERS
8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
8.2.2 PROTON BEAM THERAPY
8.2.3 STEREOTACTIC RADIATION THERAPY
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
8.2.7 OTHERS
8.3 INTERNAL RADIATION THERAPY
8.3.1 BRACHYTHERAPY
8.3.2 INTRAOPERATIVE RADIATION THERAPY (IORT)
8.3.3 OTHERS
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BREAST CANCER
9.3 LUNG CANCER
9.4 PROSTATE CANCER
9.5 COLORECTAL CANCER
9.6 LYMPHOMA
9.7 LIVER CANCER
9.8 THYROID CANCER
9.9 BRAIN CANCER
9.1 CERVICAL CANCER
9.11 SPINE CANCER
9.12 OTHERS
10 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 RADIATION THERAPY CENTERS
10.4 SPECIALTY CLINICS
10.5 OTHERS
11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY GEOGRAPHY
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 AUSTRALIA
12.1.4 INDIA
12.1.5 SOUTH KOREA
12.1.6 NEW ZEALAND
12.1.7 SINGAPORE
12.1.8 THAILAND
12.1.9 MALAYSIA
12.1.10 VIETNAM
12.1.11 TAIWAN
12.1.12 INDONESIA
12.1.13 PHILIPPINES
12.1.14 REST OF ASIA-PACIFIC
13 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ELEKTA
15.1.1 COMPANY SNAPSHOT
15.2 REVENUE ANALYSIS
15.2.1 PRODUCT PORTFOLIO
15.2.2 RECENT DEVELOPMENTS
15.3 GENERAL ELECTRIC COMPANY
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 CANON MEDICAL SYSTEMS CORPORATION
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 HITACHI, LTD.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 SIEMENS HEALTHCARE GMBH
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 ACCURACY INCORPORATED
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BEBIG MEDICAL.
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 BRAINLAB
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 ECKERT & ZIEGLER BEBIG
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 IBA WORLDWIDE
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 KONINKLIJKE PHILIPS N.V.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 LINATECH INC
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 MEVION MEDICAL SYSTEMS
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 SHINVA MEDICAL INSTRUMENT CO., LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 UNITED IMAGING HEALTHCARE CO., LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.18 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
15.19 ZEISS INTERNATIONAL
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
Lista de Tablas
TABLE 1 ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 2 ASIA-PACIFIC PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 4 ASIA-PACIFIC PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC INTERNAL RADIATION RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 6 ASIA-PACIFIC SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 8 ASIA-PACIFIC RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 ASIA-PACIFIC INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 ASIA-PACIFIC RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 14 ASIA-PACIFIC RADIOTHERAPY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 15 CHINA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 16 CHINA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 17 CHINA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 18 CHINA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 19 CHINA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 20 CHINA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 21 CHINA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 22 CHINA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 23 CHINA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 CHINA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 CHINA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 CHINA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 CHINA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 28 JAPAN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 29 JAPAN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 30 JAPAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 31 JAPAN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 32 JAPAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 33 JAPAN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 34 JAPAN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 35 JAPAN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 36 JAPAN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 JAPAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 JAPAN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 JAPAN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 JAPAN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 AUSTRALIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 42 AUSTRALIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 43 AUSTRALIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 44 AUSTRALIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 45 AUSTRALIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 46 AUSTRALIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 47 AUSTRALIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 48 AUSTRALIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 49 AUSTRALIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 50 AUSTRALIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 AUSTRALIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 AUSTRALIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 AUSTRALIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 INDIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 55 INDIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 56 INDIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 57 INDIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 58 INDIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 59 INDIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 60 INDIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 61 INDIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 INDIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 63 INDIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 INDIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 65 INDIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 INDIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 SOUTH KOREA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 68 SOUTH KOREA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 69 SOUTH KOREA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 70 SOUTH KOREA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 71 SOUTH KOREA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 72 SOUTH KOREA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 73 SOUTH KOREA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 74 SOUTH KOREA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 SOUTH KOREA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 SOUTH KOREA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SOUTH KOREA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 SOUTH KOREA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 SOUTH KOREA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 80 NEW ZEALAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 81 NEW ZEALAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 82 NEW ZEALAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 83 NEW ZEALAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 84 NEW ZEALAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 85 NEW ZEALAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 86 NEW ZEALAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 87 NEW ZEALAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 NEW ZEALAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 NEW ZEALAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 NEW ZEALAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 NEW ZEALAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 NEW ZEALAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 93 SINGAPORE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 94 SINGAPORE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 95 SINGAPORE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 96 SINGAPORE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 97 SINGAPORE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 98 SINGAPORE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 99 SINGAPORE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 100 SINGAPORE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 SINGAPORE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 SINGAPORE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 SINGAPORE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 SINGAPORE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 105 SINGAPORE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 106 THAILAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 107 THAILAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 108 THAILAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 109 THAILAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 110 THAILAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 111 THAILAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 112 THAILAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 113 THAILAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 THAILAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 115 THAILAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 THAILAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 THAILAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 THAILAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 MALAYSIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 120 MALAYSIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 121 MALAYSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 122 MALAYSIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 123 MALAYSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 124 MALAYSIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 125 MALAYSIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 126 MALAYSIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 MALAYSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 MALAYSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 MALAYSIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 MALAYSIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 MALAYSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 VIETNAM RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 133 VIETNAM PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 134 VIETNAM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 135 VIETNAM PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 136 VIETNAM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 137 VIETNAM SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 138 VIETNAM SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 139 VIETNAM RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 VIETNAM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 VIETNAM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 VIETNAM RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 VIETNAM RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 144 VIETNAM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 TAIWAN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 146 TAIWAN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 147 TAIWAN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 148 TAIWAN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 149 TAIWAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 150 TAIWAN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 151 TAIWAN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 152 TAIWAN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 TAIWAN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 TAIWAN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 TAIWAN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 TAIWAN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 157 TAIWAN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 INDONESIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 159 INDONESIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 160 INDONESIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 161 INDONESIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 162 INDONESIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 163 INDONESIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 165 INDONESIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 166 INDONESIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 170 INDONESIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 171 PHILIPPINES RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 172 PHILIPPINES PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 173 PHILIPPINES EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 174 PHILIPPINES PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 175 PHILIPPINES INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 176 PHILIPPINES SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 177 PHILIPPINES SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 178 PHILIPPINES RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 179 PHILIPPINES EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 180 PHILIPPINES INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 181 PHILIPPINES RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 182 PHILIPPINES RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 183 PHILIPPINES RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 REST OF ASIA-PACIFIC RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
Lista de figuras
FIGURE 1 ASIA-PACIFIC RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC RADIOTHERAPY MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC RADIOTHERAPY MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 ASIA-PACIFIC RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 10 THE GROWING PREVALANCE OF CANCER DISEASE AND NOVEL TECHNOLOGIES IN RADIOTHEAPY FOR CANCER TREATMENT ARE EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC RADIOTHERAPY MARKET FROM 2023 TO 2030
FIGURE 11 THE SERVICES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC RADIOTHERAPY MARKET IN 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC RADIOTHERAPY MARKET
FIGURE 13 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2022
FIGURE 14 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2023-2030 (USD MILLION)
FIGURE 15 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2023-2030)
FIGURE 16 ASIA-PACIFIC RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 17 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, 2022
FIGURE 18 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 19 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 20 ASIA-PACIFIC RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, 2022
FIGURE 22 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 23 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 24 ASIA-PACIFIC RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 25 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, 2022
FIGURE 26 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 27 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 28 ASIA-PACIFIC RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE
FIGURE 29 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 30 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 31 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 32 ASIA-PACIFIC RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 ASIA-PACIFIC RADIOTHERAPY MARKET: BY SNAPSHOT (2022)
FIGURE 34 ASIA-PACIFIC RADIOTHERAPY MARKET: COMPANY SHARE 2022 (%)
Metodología de investigación
La recopilación de datos y el análisis del año base se realizan utilizando módulos de recopilación de datos con muestras de gran tamaño. La etapa incluye la obtención de información de mercado o datos relacionados a través de varias fuentes y estrategias. Incluye el examen y la planificación de todos los datos adquiridos del pasado con antelación. Asimismo, abarca el examen de las inconsistencias de información observadas en diferentes fuentes de información. Los datos de mercado se analizan y estiman utilizando modelos estadísticos y coherentes de mercado. Además, el análisis de la participación de mercado y el análisis de tendencias clave son los principales factores de éxito en el informe de mercado. Para obtener más información, solicite una llamada de un analista o envíe su consulta.
La metodología de investigación clave utilizada por el equipo de investigación de DBMR es la triangulación de datos, que implica la extracción de datos, el análisis del impacto de las variables de datos en el mercado y la validación primaria (experto en la industria). Los modelos de datos incluyen cuadrícula de posicionamiento de proveedores, análisis de línea de tiempo de mercado, descripción general y guía del mercado, cuadrícula de posicionamiento de la empresa, análisis de patentes, análisis de precios, análisis de participación de mercado de la empresa, estándares de medición, análisis global versus regional y de participación de proveedores. Para obtener más información sobre la metodología de investigación, envíe una consulta para hablar con nuestros expertos de la industria.
Personalización disponible
Data Bridge Market Research es líder en investigación formativa avanzada. Nos enorgullecemos de brindar servicios a nuestros clientes existentes y nuevos con datos y análisis que coinciden y se adaptan a sus objetivos. El informe se puede personalizar para incluir análisis de tendencias de precios de marcas objetivo, comprensión del mercado de países adicionales (solicite la lista de países), datos de resultados de ensayos clínicos, revisión de literatura, análisis de mercado renovado y base de productos. El análisis de mercado de competidores objetivo se puede analizar desde análisis basados en tecnología hasta estrategias de cartera de mercado. Podemos agregar tantos competidores sobre los que necesite datos en el formato y estilo de datos que esté buscando. Nuestro equipo de analistas también puede proporcionarle datos en archivos de Excel sin procesar, tablas dinámicas (libro de datos) o puede ayudarlo a crear presentaciones a partir de los conjuntos de datos disponibles en el informe.
